产品
编 号:F762975
分子式:C26H23N3O6S4
分子量:601.74
产品类型
结构图
CAS No: 3031666-31-3
联系客服
产品详情
生物活性:
hCAIX/XII-IN-6 is an orally active carbonic anhydrase (CA) inhibitor. hCAIX/XII-IN-6 inhibits human CA isoforms hCA I, II, IV, IX, and XII with Ki values of 6697 nM, 2950 nM, 4093 nM, 4.1 nM and 7.7 nM, respectively. hCAIX/XII-IN-6 can be used for the research of rheumatoid arthritis (RA).
体内研究:
hCAIX/XII-IN-6 (oral; 1, 10, 30 mg/kg; single) completely reverts the pain state 45 min after administration and enhances antihyperalgesic effect in vivo.Animal Model:adjuvant-induced arthritis rat model
Dosage:1, 10, 30 mg/kg
Administration:oral, single
Result:Evoked an antihypersensitivity effect in a dose-dependent manner.Reduced spontaneous pain in a dose-dependent mannerwith a peak of efficacy between 30 and 45 min.
体外研究:
hCAIX/XII-IN-6 has inhibition activitr for human CA isoforms hCA I, II,IV, IX, and XII with Ki values of 6697 nM, 2950 nM, 4093 nM, 4.1 nM and 7.7 nM, respectively.hCAIX/XII-IN-6 (150 μM) exhibits a weaker H2S releas.